Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine - Top-Institutions - MDSpire

Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine

  • By

  • Andrea Surnit

  • April 24, 2026

  • 3 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID)
    National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Pediatric Infectious Diseases
    • Vaccine Research
    • Immunology
  • #2

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, TN

    Key Differentiators

    • Pediatric Infectious Diseases
    • Vaccine Development
  • #3

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Infectious Diseases
    • Vaccine Research
  • #4

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Infectious Diseases
    • Vaccine Development
  • #5

    Institut Pasteur
    Institut Pasteur

    Paris, France

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Vaccine Research

Original Source(s)

Related Content